cyproterone acetate has been researched along with cholecalciferol in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Heikkinen, AM; Penttilä, I; Saarikoski, S; Tuppurainen, M | 1 |
| Heikkinen, AM; Komulainen, M; Kröger, H; Niskanen, L; Parviainen, M; Saarikoski, S; Tuppurainen, MT | 1 |
| Alhava, E; Heikkinen, AM; Honkanen, R; Jurvelin, J; Komulainen, M; Kröger, H; Puntila, E; Saarikoski, S; Tuppurainen, MT | 1 |
| Alhava, E; Heikkinen, AM; Honkanen, R; Jurvelin, J; Komulainen, M; Kröger, H; Saarikoski, S; Tuppurainen, MT | 1 |
| Heikkinen, AM; Honkanen, R; Komulainen, M; Kröger, H; Mäenpää, PH; Mahonen, A; Pallonen, H; Saarikoski, S; Salmén, T | 1 |
5 trial(s) available for cyproterone acetate and cholecalciferol
| Article | Year |
|---|---|
Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3.
Topics: Cholecalciferol; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Climacteric; Cyproterone Acetate; Dose-Response Relationship, Drug; Drug Administration Schedule; Estradiol; Estrogen Replacement Therapy; Female; Humans; Lipids; Middle Aged; Prospective Studies | 1995 |
Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D3: a prospective, controlled, randomized study.
Topics: Alkaline Phosphatase; Biomarkers; Bone Density; Cholecalciferol; Collagen; Collagen Type I; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Female; Finland; Humans; Middle Aged; Osteocalcin; Peptides; Placebos; Postmenopause; Prospective Studies | 1997 |
Does vitamin D strengthen the increase in femoral neck BMD in osteoporotic women treated with estrogen?
Topics: Androgen Antagonists; Bone Density; Cholecalciferol; Cyproterone Acetate; Drug Therapy, Combination; Estradiol; Estrogen Replacement Therapy; Female; Femur Neck; Humans; Middle Aged; Osteoporosis, Postmenopausal; Statistics, Nonparametric | 1998 |
Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial.
Topics: Cholecalciferol; Cyproterone Acetate; Estradiol; Estrogen Replacement Therapy; Female; Femur; Humans; Lumbar Vertebrae; Middle Aged; Osteoporosis, Postmenopausal; Placebos; Postmenopause | 1999 |
Relation of androgen receptor gene polymorphism to bone mineral density and fracture risk in early postmenopausal women during a 5-year randomized hormone replacement therapy trial.
Topics: Aged; Alleles; Bone Density; Cholecalciferol; Cyproterone Acetate; Estradiol; Exons; Female; Fractures, Bone; Genotype; Hormone Replacement Therapy; Humans; Middle Aged; Polymorphism, Genetic; Postmenopause; Random Allocation; Receptors, Androgen; Time Factors | 2003 |
1 other study(ies) available for cyproterone acetate and cholecalciferol
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |